C. Lowry Barnes
Concepts (444)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 57 | 2024 | 282 | 13.480 |
Why?
| Arthroplasty, Replacement, Hip | 52 | 2024 | 261 | 13.380 |
Why?
| Orthopedics | 10 | 2022 | 52 | 2.590 |
Why?
| Osteoarthritis, Knee | 11 | 2022 | 88 | 2.430 |
Why?
| Health Literacy | 5 | 2019 | 128 | 2.150 |
Why?
| Length of Stay | 18 | 2024 | 619 | 2.140 |
Why?
| Patient Readmission | 13 | 2024 | 219 | 1.930 |
Why?
| Knee Joint | 19 | 2023 | 162 | 1.920 |
Why?
| Reoperation | 13 | 2024 | 454 | 1.910 |
Why?
| Antibodies, Neutralizing | 11 | 2023 | 64 | 1.900 |
Why?
| Coronavirus Infections | 8 | 2021 | 177 | 1.860 |
Why?
| Pneumonia, Viral | 7 | 2020 | 168 | 1.860 |
Why?
| Aged | 53 | 2024 | 9310 | 1.830 |
Why?
| Analgesics, Opioid | 10 | 2024 | 552 | 1.820 |
Why?
| Humans | 135 | 2024 | 49974 | 1.810 |
Why?
| Arthroplasty, Replacement | 5 | 2019 | 27 | 1.800 |
Why?
| Medicare | 17 | 2024 | 246 | 1.800 |
Why?
| Hip Prosthesis | 6 | 2021 | 71 | 1.790 |
Why?
| Preoperative Care | 5 | 2018 | 164 | 1.710 |
Why?
| Retrospective Studies | 43 | 2024 | 6108 | 1.610 |
Why?
| Antibodies, Viral | 10 | 2023 | 88 | 1.430 |
Why?
| United States | 27 | 2024 | 4860 | 1.430 |
Why?
| Pandemics | 11 | 2022 | 559 | 1.420 |
Why?
| Periprosthetic Fractures | 4 | 2022 | 12 | 1.390 |
Why?
| Postoperative Complications | 13 | 2024 | 984 | 1.360 |
Why?
| Pain, Postoperative | 7 | 2024 | 158 | 1.340 |
Why?
| Prosthesis-Related Infections | 6 | 2023 | 104 | 1.290 |
Why?
| Range of Motion, Articular | 8 | 2022 | 108 | 1.290 |
Why?
| Joint Diseases | 3 | 2018 | 41 | 1.270 |
Why?
| Golf | 3 | 2023 | 9 | 1.240 |
Why?
| Critical Pathways | 3 | 2017 | 39 | 1.230 |
Why?
| Patient Discharge | 14 | 2022 | 320 | 1.230 |
Why?
| Hip Dislocation | 2 | 2019 | 17 | 1.200 |
Why?
| Orthopedic Procedures | 6 | 2020 | 68 | 1.190 |
Why?
| Patient Education as Topic | 4 | 2018 | 302 | 1.130 |
Why?
| Comprehension | 2 | 2018 | 110 | 1.130 |
Why?
| Middle Aged | 38 | 2024 | 12069 | 1.060 |
Why?
| Prosthesis Failure | 5 | 2020 | 107 | 1.010 |
Why?
| Immunoglobulin G | 5 | 2021 | 186 | 1.010 |
Why?
| Pain Management | 3 | 2016 | 160 | 0.960 |
Why?
| Osteoarthritis | 6 | 2023 | 62 | 0.960 |
Why?
| Joint Instability | 2 | 2022 | 40 | 0.960 |
Why?
| Male | 52 | 2024 | 25241 | 0.950 |
Why?
| Risk Factors | 18 | 2023 | 3613 | 0.890 |
Why?
| Hip | 2 | 2020 | 25 | 0.870 |
Why?
| Opioid-Related Disorders | 5 | 2023 | 381 | 0.840 |
Why?
| Lordosis | 1 | 2022 | 4 | 0.830 |
Why?
| Prosthesis Design | 4 | 2021 | 237 | 0.830 |
Why?
| Kyphosis | 1 | 2022 | 15 | 0.830 |
Why?
| Hospitals | 10 | 2024 | 175 | 0.820 |
Why?
| Knee | 3 | 2021 | 22 | 0.810 |
Why?
| Female | 48 | 2024 | 26472 | 0.790 |
Why?
| Air Pollution, Indoor | 4 | 2014 | 25 | 0.790 |
Why?
| Transurethral Resection of Prostate | 1 | 2021 | 10 | 0.760 |
Why?
| Blood Transfusion | 3 | 2016 | 121 | 0.760 |
Why?
| Prostatic Hyperplasia | 1 | 2021 | 39 | 0.750 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2020 | 16 | 0.730 |
Why?
| Knee Prosthesis | 4 | 2023 | 49 | 0.730 |
Why?
| Aged, 80 and over | 13 | 2024 | 3129 | 0.690 |
Why?
| Housing | 3 | 2015 | 46 | 0.670 |
Why?
| Anesthesia, General | 4 | 2024 | 91 | 0.670 |
Why?
| Surgery Department, Hospital | 1 | 2019 | 4 | 0.660 |
Why?
| Bone Cements | 1 | 2019 | 31 | 0.660 |
Why?
| Diabetic Foot | 1 | 2019 | 51 | 0.660 |
Why?
| Societies, Medical | 2 | 2020 | 175 | 0.650 |
Why?
| Polymethyl Methacrylate | 1 | 2019 | 26 | 0.650 |
Why?
| Hip Joint | 2 | 2020 | 57 | 0.650 |
Why?
| Cost Savings | 2 | 2017 | 58 | 0.630 |
Why?
| Comorbidity | 5 | 2018 | 615 | 0.620 |
Why?
| Allergens | 4 | 2016 | 139 | 0.620 |
Why?
| Arthroplasty | 4 | 2023 | 28 | 0.610 |
Why?
| Fungi | 3 | 2008 | 44 | 0.610 |
Why?
| Yoga | 1 | 2018 | 17 | 0.610 |
Why?
| Hospitals, Teaching | 2 | 2019 | 53 | 0.590 |
Why?
| Inpatients | 7 | 2020 | 190 | 0.580 |
Why?
| Clinical Protocols | 1 | 2017 | 108 | 0.580 |
Why?
| Postoperative Period | 6 | 2018 | 170 | 0.570 |
Why?
| Dust | 2 | 2015 | 22 | 0.570 |
Why?
| Arthritis, Infectious | 3 | 2023 | 44 | 0.560 |
Why?
| Quadriceps Muscle | 4 | 2022 | 46 | 0.560 |
Why?
| Patient Navigation | 1 | 2016 | 12 | 0.560 |
Why?
| Antifibrinolytic Agents | 1 | 2016 | 16 | 0.550 |
Why?
| Anti-Bacterial Agents | 4 | 2023 | 744 | 0.540 |
Why?
| Tranexamic Acid | 1 | 2016 | 15 | 0.540 |
Why?
| Early Ambulation | 1 | 2016 | 6 | 0.540 |
Why?
| Musculoskeletal Pain | 1 | 2016 | 7 | 0.540 |
Why?
| Caregivers | 1 | 2018 | 208 | 0.530 |
Why?
| Publishing | 1 | 2016 | 39 | 0.510 |
Why?
| Quality of Health Care | 1 | 2017 | 186 | 0.510 |
Why?
| Periodicals as Topic | 1 | 2016 | 58 | 0.500 |
Why?
| Analgesia, Epidural | 1 | 2015 | 28 | 0.490 |
Why?
| Bupivacaine | 1 | 2015 | 28 | 0.490 |
Why?
| Intermittent Pneumatic Compression Devices | 1 | 2014 | 2 | 0.470 |
Why?
| Narcotics | 3 | 2020 | 111 | 0.470 |
Why?
| Epilepsy | 1 | 2016 | 174 | 0.460 |
Why?
| Exercise | 1 | 2018 | 495 | 0.460 |
Why?
| Treatment Outcome | 10 | 2024 | 5141 | 0.460 |
Why?
| Adult | 22 | 2024 | 13236 | 0.450 |
Why?
| Venous Thromboembolism | 1 | 2014 | 68 | 0.430 |
Why?
| Air Pollutants | 1 | 2013 | 60 | 0.420 |
Why?
| Activities of Daily Living | 3 | 2023 | 174 | 0.410 |
Why?
| Health Expenditures | 3 | 2017 | 67 | 0.410 |
Why?
| Odds Ratio | 7 | 2019 | 545 | 0.400 |
Why?
| Asthma | 5 | 2015 | 281 | 0.390 |
Why?
| Osteonecrosis | 2 | 2022 | 34 | 0.390 |
Why?
| Epitopes | 5 | 2023 | 59 | 0.380 |
Why?
| Lower Extremity | 3 | 2023 | 88 | 0.370 |
Why?
| Acetabulum | 3 | 2020 | 38 | 0.350 |
Why?
| Pain | 4 | 2024 | 379 | 0.340 |
Why?
| Models, Molecular | 5 | 2021 | 338 | 0.340 |
Why?
| Tibial Fractures | 2 | 2021 | 32 | 0.330 |
Why?
| Osteoarthritis, Hip | 3 | 2019 | 25 | 0.330 |
Why?
| Cryoelectron Microscopy | 4 | 2021 | 9 | 0.330 |
Why?
| Cost-Benefit Analysis | 3 | 2021 | 274 | 0.330 |
Why?
| Fee-for-Service Plans | 2 | 2020 | 11 | 0.320 |
Why?
| Cross-Sectional Studies | 5 | 2016 | 1557 | 0.320 |
Why?
| B-Lymphocytes | 4 | 2021 | 170 | 0.310 |
Why?
| Movement | 4 | 2021 | 82 | 0.310 |
Why?
| Patient Satisfaction | 2 | 2020 | 273 | 0.300 |
Why?
| Neutralization Tests | 6 | 2023 | 24 | 0.300 |
Why?
| Humidity | 1 | 2007 | 6 | 0.290 |
Why?
| Viscosupplements | 2 | 2017 | 14 | 0.290 |
Why?
| Respiratory Hypersensitivity | 1 | 2007 | 17 | 0.290 |
Why?
| Hyaluronic Acid | 2 | 2017 | 34 | 0.290 |
Why?
| Respiratory Tract Diseases | 1 | 2007 | 24 | 0.290 |
Why?
| Risk | 2 | 2017 | 320 | 0.260 |
Why?
| Mutation | 5 | 2021 | 1294 | 0.250 |
Why?
| Young Adult | 8 | 2021 | 3958 | 0.250 |
Why?
| Logistic Models | 3 | 2016 | 888 | 0.250 |
Why?
| Muscle Strength | 3 | 2022 | 124 | 0.250 |
Why?
| Antibodies, Monoclonal | 7 | 2021 | 459 | 0.250 |
Why?
| Arthralgia | 3 | 2022 | 43 | 0.240 |
Why?
| Hip Fractures | 2 | 2023 | 47 | 0.240 |
Why?
| Hospital Mortality | 2 | 2016 | 409 | 0.230 |
Why?
| Public Opinion | 2 | 2021 | 20 | 0.230 |
Why?
| Cross Reactions | 2 | 2021 | 42 | 0.230 |
Why?
| Femur | 2 | 2021 | 133 | 0.230 |
Why?
| Antibiotic Prophylaxis | 1 | 2023 | 61 | 0.220 |
Why?
| Poverty | 2 | 2015 | 201 | 0.220 |
Why?
| Reproducibility of Results | 3 | 2022 | 1193 | 0.220 |
Why?
| Knee Injuries | 1 | 2023 | 27 | 0.220 |
Why?
| Adolescent | 9 | 2021 | 6356 | 0.210 |
Why?
| Femoral Fractures | 1 | 2023 | 39 | 0.210 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 36 | 0.210 |
Why?
| Braces | 1 | 2002 | 9 | 0.210 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.210 |
Why?
| Gait | 2 | 2021 | 85 | 0.210 |
Why?
| Myositis | 1 | 2022 | 18 | 0.200 |
Why?
| Outpatients | 2 | 2020 | 113 | 0.200 |
Why?
| Pain Measurement | 3 | 2019 | 240 | 0.200 |
Why?
| Pelvis | 1 | 2022 | 68 | 0.200 |
Why?
| Injections, Intra-Articular | 3 | 2017 | 33 | 0.200 |
Why?
| Antibody Affinity | 1 | 2021 | 7 | 0.200 |
Why?
| Databases, Factual | 4 | 2019 | 658 | 0.200 |
Why?
| Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.200 |
Why?
| Cost of Illness | 1 | 2022 | 117 | 0.200 |
Why?
| Anemia, Sickle Cell | 1 | 2022 | 96 | 0.190 |
Why?
| Lumbar Vertebrae | 1 | 2022 | 98 | 0.190 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 22 | 0.190 |
Why?
| Radiography | 5 | 2019 | 489 | 0.190 |
Why?
| Crowdsourcing | 1 | 2021 | 8 | 0.190 |
Why?
| Multiple Myeloma | 1 | 2016 | 2929 | 0.190 |
Why?
| Immunity, Humoral | 1 | 2021 | 22 | 0.190 |
Why?
| Posture | 1 | 2021 | 59 | 0.190 |
Why?
| Receptors, Virus | 1 | 2020 | 24 | 0.190 |
Why?
| Joints | 2 | 2018 | 18 | 0.190 |
Why?
| Femur Head Necrosis | 1 | 2020 | 18 | 0.190 |
Why?
| Dissociative Disorders | 1 | 2020 | 6 | 0.180 |
Why?
| Epitope Mapping | 1 | 2020 | 6 | 0.180 |
Why?
| Adrenal Cortex Hormones | 2 | 2020 | 94 | 0.180 |
Why?
| Decompression, Surgical | 1 | 2020 | 51 | 0.180 |
Why?
| Immunization, Passive | 1 | 2020 | 29 | 0.180 |
Why?
| Bariatric Surgery | 1 | 2021 | 40 | 0.180 |
Why?
| Polyethylene | 1 | 2020 | 18 | 0.180 |
Why?
| Diagnosis-Related Groups | 2 | 2017 | 18 | 0.180 |
Why?
| Tobacco Smoke Pollution | 2 | 2014 | 48 | 0.180 |
Why?
| Obesity, Morbid | 1 | 2021 | 78 | 0.180 |
Why?
| Antibodies, Bispecific | 1 | 2021 | 60 | 0.180 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 134 | 0.180 |
Why?
| Foot Orthoses | 1 | 2019 | 5 | 0.170 |
Why?
| External Fixators | 1 | 2019 | 9 | 0.170 |
Why?
| Fracture Healing | 2 | 1996 | 27 | 0.170 |
Why?
| Tobramycin | 1 | 2019 | 15 | 0.170 |
Why?
| Nanoparticles | 1 | 2021 | 145 | 0.170 |
Why?
| After-Hours Care | 1 | 2019 | 11 | 0.170 |
Why?
| Recombinant Proteins | 1 | 2020 | 486 | 0.170 |
Why?
| Antiviral Agents | 1 | 2020 | 173 | 0.170 |
Why?
| Hematologic Neoplasms | 1 | 2020 | 99 | 0.160 |
Why?
| Prostheses and Implants | 1 | 2019 | 54 | 0.160 |
Why?
| Postural Balance | 2 | 2021 | 56 | 0.160 |
Why?
| Hospitals, University | 1 | 2019 | 77 | 0.160 |
Why?
| Sepsis | 1 | 2021 | 220 | 0.160 |
Why?
| Healthcare Disparities | 1 | 2022 | 257 | 0.160 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 46 | 0.160 |
Why?
| Multiple Sclerosis | 1 | 2019 | 66 | 0.160 |
Why?
| Rural Population | 1 | 2023 | 540 | 0.160 |
Why?
| Vancomycin | 1 | 2019 | 81 | 0.160 |
Why?
| Exercise Test | 1 | 2019 | 121 | 0.160 |
Why?
| Medicaid | 2 | 2022 | 257 | 0.160 |
Why?
| Drug Prescriptions | 1 | 2019 | 95 | 0.150 |
Why?
| Rotation | 1 | 2018 | 45 | 0.150 |
Why?
| Recreation | 1 | 2018 | 20 | 0.150 |
Why?
| Microbial Sensitivity Tests | 1 | 2019 | 269 | 0.150 |
Why?
| Benzodiazepines | 1 | 2018 | 70 | 0.150 |
Why?
| Tramadol | 1 | 2018 | 30 | 0.150 |
Why?
| Guidelines as Topic | 1 | 2018 | 111 | 0.150 |
Why?
| Body Mass Index | 2 | 2018 | 652 | 0.150 |
Why?
| Incidence | 3 | 2019 | 1003 | 0.150 |
Why?
| Subacute Care | 1 | 2017 | 5 | 0.150 |
Why?
| Recovery of Function | 1 | 2018 | 188 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2018 | 144 | 0.150 |
Why?
| Language | 1 | 2018 | 133 | 0.140 |
Why?
| Immunologic Memory | 3 | 2021 | 30 | 0.140 |
Why?
| Fractures, Open | 1 | 1996 | 7 | 0.140 |
Why?
| Nut Hypersensitivity | 1 | 2016 | 3 | 0.140 |
Why?
| Cocos | 1 | 2016 | 3 | 0.140 |
Why?
| Patient Safety | 1 | 2017 | 102 | 0.140 |
Why?
| Fractures, Bone | 4 | 1992 | 107 | 0.140 |
Why?
| Nuts | 1 | 2016 | 9 | 0.140 |
Why?
| Football | 1 | 2018 | 72 | 0.140 |
Why?
| Time Factors | 5 | 2021 | 2903 | 0.140 |
Why?
| Hospitals, Community | 1 | 2016 | 17 | 0.140 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 244 | 0.130 |
Why?
| Social Support | 1 | 2018 | 263 | 0.130 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 95 | 0.130 |
Why?
| Quality Improvement | 1 | 2018 | 208 | 0.130 |
Why?
| Anesthesia, Spinal | 1 | 2016 | 16 | 0.130 |
Why?
| Peer Review, Research | 1 | 2016 | 13 | 0.130 |
Why?
| Anemia | 1 | 2016 | 68 | 0.130 |
Why?
| Congresses as Topic | 1 | 2016 | 44 | 0.130 |
Why?
| Hypersensitivity | 2 | 2008 | 77 | 0.130 |
Why?
| Hemoglobins | 1 | 2016 | 107 | 0.130 |
Why?
| Anesthesia, Conduction | 1 | 2016 | 17 | 0.130 |
Why?
| Prescription Drug Misuse | 1 | 2016 | 31 | 0.130 |
Why?
| Risk Reduction Behavior | 1 | 2016 | 59 | 0.130 |
Why?
| Hyperalgesia | 1 | 2016 | 56 | 0.130 |
Why?
| Chronic Disease | 1 | 2018 | 567 | 0.130 |
Why?
| Pneumonia | 1 | 2016 | 118 | 0.130 |
Why?
| Ambulatory Care Facilities | 1 | 2016 | 125 | 0.130 |
Why?
| Injections, Epidural | 1 | 2015 | 10 | 0.130 |
Why?
| Liposomes | 1 | 2015 | 48 | 0.120 |
Why?
| Arthroplasty, Replacement, Ankle | 1 | 2014 | 3 | 0.120 |
Why?
| Multivariate Analysis | 1 | 2016 | 577 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.120 |
Why?
| Follow-Up Studies | 3 | 2020 | 2182 | 0.120 |
Why?
| Anesthetics, Local | 1 | 2015 | 75 | 0.120 |
Why?
| Age Factors | 1 | 2017 | 1087 | 0.120 |
Why?
| Smoking | 1 | 2018 | 511 | 0.120 |
Why?
| Delivery of Health Care | 1 | 2017 | 309 | 0.120 |
Why?
| Bacteria | 1 | 2015 | 224 | 0.110 |
Why?
| Drug Overdose | 1 | 2016 | 159 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2017 | 285 | 0.110 |
Why?
| Arthropod Proteins | 1 | 2013 | 1 | 0.110 |
Why?
| Antigens, Dermatophagoides | 1 | 2013 | 3 | 0.110 |
Why?
| Humeral Fractures | 1 | 1992 | 8 | 0.110 |
Why?
| Cysteine Endopeptidases | 1 | 2013 | 67 | 0.110 |
Why?
| Joint Prosthesis | 1 | 1992 | 12 | 0.110 |
Why?
| Child | 9 | 2020 | 6847 | 0.110 |
Why?
| Patient Positioning | 1 | 2013 | 32 | 0.110 |
Why?
| Venous Thrombosis | 1 | 2014 | 90 | 0.110 |
Why?
| Acute Kidney Injury | 1 | 2016 | 284 | 0.110 |
Why?
| Environmental Monitoring | 1 | 2013 | 65 | 0.110 |
Why?
| Pulmonary Embolism | 1 | 2014 | 97 | 0.110 |
Why?
| Child, Preschool | 7 | 2016 | 3871 | 0.110 |
Why?
| Carpal Bones | 1 | 1992 | 2 | 0.110 |
Why?
| Synostosis | 1 | 1992 | 2 | 0.110 |
Why?
| Shoulder Joint | 1 | 1992 | 38 | 0.100 |
Why?
| Mass Screening | 1 | 2016 | 353 | 0.100 |
Why?
| Mice | 5 | 2023 | 5739 | 0.100 |
Why?
| Diseases in Twins | 1 | 1992 | 15 | 0.100 |
Why?
| Glycoproteins | 1 | 2013 | 115 | 0.100 |
Why?
| Ambulatory Care | 1 | 2014 | 222 | 0.100 |
Why?
| Arm Injuries | 1 | 1991 | 10 | 0.100 |
Why?
| Tibia | 2 | 2023 | 117 | 0.100 |
Why?
| Fungal Proteins | 1 | 2013 | 118 | 0.100 |
Why?
| Socioeconomic Factors | 3 | 2023 | 581 | 0.100 |
Why?
| Animals | 7 | 2023 | 13187 | 0.100 |
Why?
| Immune Evasion | 2 | 2021 | 11 | 0.100 |
Why?
| Aging | 1 | 1996 | 687 | 0.100 |
Why?
| Lidocaine | 1 | 1991 | 49 | 0.100 |
Why?
| Immunoglobulin E | 2 | 2016 | 92 | 0.100 |
Why?
| Epitopes, B-Lymphocyte | 2 | 2021 | 4 | 0.100 |
Why?
| Nerve Block | 1 | 1991 | 38 | 0.100 |
Why?
| Mental Disorders | 1 | 2016 | 396 | 0.100 |
Why?
| Immunoglobulin A | 2 | 2021 | 45 | 0.100 |
Why?
| Stroke | 1 | 2016 | 492 | 0.100 |
Why?
| Antigens, Viral | 2 | 2021 | 44 | 0.090 |
Why?
| Immunoglobulin M | 2 | 2021 | 52 | 0.090 |
Why?
| Mycotoxins | 2 | 2008 | 12 | 0.090 |
Why?
| Cohort Studies | 3 | 2021 | 1422 | 0.090 |
Why?
| Protein Binding | 2 | 2021 | 660 | 0.080 |
Why?
| Obesity | 1 | 2017 | 1113 | 0.080 |
Why?
| Kinetics | 2 | 2021 | 623 | 0.080 |
Why?
| Phylogeny | 2 | 2021 | 235 | 0.080 |
Why?
| Environmental Illness | 1 | 2007 | 1 | 0.070 |
Why?
| Sick Building Syndrome | 1 | 2007 | 1 | 0.070 |
Why?
| Muscle, Skeletal | 2 | 2022 | 750 | 0.070 |
Why?
| Propensity Score | 2 | 2017 | 123 | 0.070 |
Why?
| Inflammation | 2 | 2022 | 604 | 0.070 |
Why?
| Quality of Life | 2 | 2022 | 836 | 0.070 |
Why?
| Hospitalization | 2 | 2020 | 652 | 0.060 |
Why?
| Air | 1 | 2005 | 23 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 449 | 0.060 |
Why?
| Polyethylenes | 2 | 2023 | 13 | 0.060 |
Why?
| Kansas | 2 | 2014 | 7 | 0.060 |
Why?
| Prospective Payment System | 1 | 2024 | 5 | 0.060 |
Why?
| 5-Methoxytryptamine | 1 | 1994 | 1 | 0.060 |
Why?
| Hydroxyindoleacetic Acid | 1 | 1994 | 8 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 1994 | 20 | 0.060 |
Why?
| Blastocyst | 1 | 1994 | 10 | 0.060 |
Why?
| Abnormalities, Drug-Induced | 1 | 1994 | 18 | 0.060 |
Why?
| Melatonin | 1 | 1994 | 16 | 0.060 |
Why?
| Fetal Diseases | 1 | 1994 | 62 | 0.060 |
Why?
| Quality Indicators, Health Care | 1 | 2024 | 86 | 0.060 |
Why?
| Health Status | 1 | 2005 | 298 | 0.050 |
Why?
| International Classification of Diseases | 1 | 2023 | 64 | 0.050 |
Why?
| Arkansas | 2 | 2019 | 1977 | 0.050 |
Why?
| Nitric Oxide | 1 | 2005 | 253 | 0.050 |
Why?
| Tertiary Care Centers | 1 | 2023 | 77 | 0.050 |
Why?
| Transplantation, Homologous | 1 | 2023 | 139 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 72 | 0.050 |
Why?
| Administration, Oral | 1 | 2023 | 426 | 0.050 |
Why?
| Health Status Indicators | 1 | 2002 | 83 | 0.050 |
Why?
| Benchmarking | 1 | 2022 | 61 | 0.050 |
Why?
| Muscles | 1 | 2022 | 103 | 0.050 |
Why?
| New York | 1 | 2021 | 47 | 0.050 |
Why?
| Chromium | 1 | 2021 | 4 | 0.050 |
Why?
| Femur Neck | 1 | 2021 | 6 | 0.050 |
Why?
| Leg | 1 | 2022 | 122 | 0.050 |
Why?
| Cobalt | 1 | 2021 | 15 | 0.050 |
Why?
| Antigen-Antibody Reactions | 1 | 2021 | 15 | 0.050 |
Why?
| Back | 1 | 2021 | 5 | 0.050 |
Why?
| Immunoglobulin Variable Region | 1 | 2021 | 13 | 0.050 |
Why?
| Antigen-Antibody Complex | 1 | 2021 | 35 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 179 | 0.050 |
Why?
| Protein Structure, Quaternary | 1 | 2021 | 26 | 0.050 |
Why?
| Torso | 1 | 2021 | 15 | 0.050 |
Why?
| Fracture Fixation, Internal | 1 | 2021 | 40 | 0.050 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 4 | 0.050 |
Why?
| Immune Sera | 1 | 2021 | 17 | 0.050 |
Why?
| HLA Antigens | 1 | 2021 | 52 | 0.050 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2021 | 7 | 0.050 |
Why?
| Indoles | 1 | 1994 | 278 | 0.050 |
Why?
| Directed Molecular Evolution | 1 | 2020 | 2 | 0.050 |
Why?
| Protein Conformation | 1 | 2021 | 166 | 0.050 |
Why?
| Immunization, Secondary | 1 | 2021 | 21 | 0.050 |
Why?
| Protein Multimerization | 1 | 2021 | 49 | 0.050 |
Why?
| Genome, Viral | 1 | 2021 | 79 | 0.050 |
Why?
| Crystallography, X-Ray | 1 | 2021 | 147 | 0.050 |
Why?
| Protein Engineering | 1 | 2020 | 18 | 0.050 |
Why?
| Fluorescent Antibody Technique | 1 | 2021 | 108 | 0.050 |
Why?
| Femur Head | 1 | 2020 | 26 | 0.050 |
Why?
| Virulence | 1 | 2021 | 173 | 0.050 |
Why?
| Immunization | 1 | 2021 | 67 | 0.050 |
Why?
| Bone Transplantation | 1 | 2020 | 47 | 0.050 |
Why?
| North America | 1 | 2020 | 64 | 0.050 |
Why?
| Cefazolin | 1 | 2020 | 12 | 0.050 |
Why?
| Endothelial Cells | 1 | 2022 | 269 | 0.050 |
Why?
| Penicillins | 1 | 2020 | 28 | 0.050 |
Why?
| Antibody Specificity | 1 | 2020 | 36 | 0.050 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 91 | 0.050 |
Why?
| Cricetinae | 1 | 2020 | 192 | 0.050 |
Why?
| Viral Vaccines | 1 | 2020 | 12 | 0.050 |
Why?
| Dependovirus | 1 | 2021 | 101 | 0.050 |
Why?
| Binding Sites | 1 | 2021 | 374 | 0.040 |
Why?
| Salvage Therapy | 1 | 2021 | 139 | 0.040 |
Why?
| Operating Rooms | 1 | 2020 | 26 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 395 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 304 | 0.040 |
Why?
| Osteoblasts | 1 | 2023 | 450 | 0.040 |
Why?
| Patella | 1 | 2019 | 12 | 0.040 |
Why?
| Osteoclasts | 1 | 2023 | 425 | 0.040 |
Why?
| Infection Control | 1 | 2020 | 50 | 0.040 |
Why?
| Aftercare | 1 | 2020 | 75 | 0.040 |
Why?
| Heel | 1 | 2019 | 5 | 0.040 |
Why?
| Shoes | 1 | 2019 | 12 | 0.040 |
Why?
| Intestines | 1 | 2021 | 176 | 0.040 |
Why?
| Sutures | 1 | 2019 | 40 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 469 | 0.040 |
Why?
| Time and Motion Studies | 1 | 2019 | 11 | 0.040 |
Why?
| Sports Equipment | 1 | 2019 | 4 | 0.040 |
Why?
| Disability Evaluation | 1 | 2019 | 87 | 0.040 |
Why?
| Software | 1 | 2021 | 273 | 0.040 |
Why?
| Physical Examination | 1 | 2019 | 90 | 0.040 |
Why?
| Telephone | 1 | 2019 | 70 | 0.040 |
Why?
| Body Weight | 1 | 2021 | 513 | 0.040 |
Why?
| Biopsy | 1 | 2021 | 584 | 0.040 |
Why?
| Electronic Health Records | 1 | 2021 | 209 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2019 | 149 | 0.040 |
Why?
| Referral and Consultation | 1 | 2020 | 285 | 0.040 |
Why?
| Morphine | 1 | 2018 | 103 | 0.040 |
Why?
| Prospective Studies | 2 | 2002 | 2364 | 0.040 |
Why?
| Linear Models | 1 | 2018 | 280 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 84 | 0.040 |
Why?
| Macadamia | 1 | 2016 | 1 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2021 | 1032 | 0.030 |
Why?
| Probability | 1 | 2016 | 164 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2015 | 23 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 1131 | 0.030 |
Why?
| Genes, Bacterial | 1 | 2015 | 64 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2021 | 1455 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2021 | 1816 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2015 | 113 | 0.030 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 486 | 0.030 |
Why?
| Corrosion | 1 | 2014 | 4 | 0.030 |
Why?
| Urban Population | 1 | 2015 | 151 | 0.030 |
Why?
| Ions | 1 | 2014 | 33 | 0.030 |
Why?
| Metals | 1 | 2014 | 34 | 0.030 |
Why?
| Prevalence | 2 | 2014 | 944 | 0.030 |
Why?
| Twins, Monozygotic | 1 | 1992 | 17 | 0.030 |
Why?
| Thrombophlebitis | 1 | 1992 | 24 | 0.030 |
Why?
| Arthritis, Rheumatoid | 1 | 1992 | 105 | 0.030 |
Why?
| Vena Cava Filters | 1 | 1992 | 34 | 0.020 |
Why?
| Injections, Intravenous | 1 | 1991 | 140 | 0.020 |
Why?
| Prognosis | 1 | 1996 | 1942 | 0.020 |
Why?
| Algorithms | 1 | 2014 | 615 | 0.020 |
Why?
| Pelvic Bones | 1 | 1990 | 12 | 0.020 |
Why?
| Dextrans | 1 | 1990 | 16 | 0.020 |
Why?
| Risk Assessment | 1 | 2014 | 1259 | 0.020 |
Why?
| Thromboembolism | 1 | 1990 | 54 | 0.020 |
Why?
| Leg Injuries | 1 | 1989 | 12 | 0.020 |
Why?
| Irritants | 1 | 2008 | 1 | 0.020 |
Why?
| Ergosterol | 1 | 2008 | 10 | 0.020 |
Why?
| Glucans | 1 | 2008 | 10 | 0.020 |
Why?
| Surgical Flaps | 1 | 1989 | 119 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 1537 | 0.020 |
Why?
| Cotinine | 1 | 2005 | 22 | 0.020 |
Why?
| Fetal Resorption | 1 | 1994 | 2 | 0.010 |
Why?
| Pineal Gland | 1 | 1994 | 7 | 0.010 |
Why?
| Fetal Death | 1 | 1994 | 23 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 1994 | 48 | 0.010 |
Why?
| Nicotine | 1 | 2005 | 187 | 0.010 |
Why?
| Organ Size | 1 | 1994 | 226 | 0.010 |
Why?
| Fetus | 1 | 1994 | 217 | 0.010 |
Why?
| Phlebography | 2 | 1992 | 61 | 0.010 |
Why?
| Pregnancy | 1 | 1994 | 2607 | 0.010 |
Why?
| Prothrombin Time | 1 | 1992 | 18 | 0.010 |
Why?
| Drug Monitoring | 1 | 1992 | 77 | 0.010 |
Why?
| Warfarin | 1 | 1992 | 86 | 0.010 |
Why?
| Urogenital System | 1 | 1990 | 5 | 0.010 |
Why?
| Multiple Trauma | 1 | 1990 | 32 | 0.010 |
Why?
| Femoral Neck Fractures | 1 | 1990 | 8 | 0.010 |
Why?
| Injury Severity Score | 1 | 1990 | 159 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 1992 | 637 | 0.010 |
Why?
|
|
Barnes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|